$9.35
0[0.00%]
At close: Apr 23
$9.35
0[0.00%]
PreMarket: 4:00PM EDT
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
Date Announced | ticker | Company Name | Period | Period Year | Min EPS | Max EPS | Estimate | Min Rev | Max Rev | Revenue Estimate | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
03/19/2024 | ENFN | Enfusion | FY | 2024 | — | — | — | $200.00M | $210.00M | $205.58M | Get Alert |
03/12/2024 | ENFN | Enfusion | FY | 2024 | — | — | — | $200.00M | $210.00M | $202.30M | Get Alert |
08/08/2023 | ENFN | Enfusion | FY | 2023 | — | — | — | $170.00M | $175.00M | $186.50M | Get Alert |
03/07/2023 | ENFN | Enfusion | FY | 2023 | — | — | — | $185.00M | $190.00M | $188.13M | Get Alert |
11/10/2022 | ENFN | Enfusion | FY | 2022 | — | — | — | $149.30M | $150.30M | $150.69M | Get Alert |
11/10/2022 | ENFN | Enfusion | Q4 | 2022 | — | — | — | $39.50M | $40.50M | $41.45M | Get Alert |
08/22/2022 | ENFN | Enfusion | FY | 2022 | — | — | — | $149.30M | $152.30M | $150.73M | Get Alert |
08/22/2022 | ENFN | Enfusion | Q3 | 2022 | — | — | — | $38.00M | $39.00M | $38.60M | Get Alert |
08/09/2022 | ENFN | Enfusion | FY | 2022 | — | — | — | $149.30M | $152.30M | $149.89M | Get Alert |
08/09/2022 | ENFN | Enfusion | Q3 | 2022 | — | — | — | $38.00M | $39.00M | $38.59M | Get Alert |
05/12/2022 | ENFN | Enfusion | FY | 2022 | — | — | — | $148.10M | $151.10M | $148.48M | Get Alert |
05/12/2022 | ENFN | Enfusion | Q2 | 2022 | — | — | — | $35.00M | $36.00M | $35.51M | Get Alert |
03/24/2022 | ENFN | Enfusion | Q1 | 2022 | — | — | — | $32.50M | $33.50M | $32.82M | Get Alert |
03/24/2022 | ENFN | Enfusion | FY | 2022 | — | — | — | $147.00M | $150.00M | $146.84M | Get Alert |
12/02/2021 | ENFN | Enfusion | Q4 | 2021 | — | — | — | $30.00M | $30.50M | $28.97M | Get Alert |
12/02/2021 | ENFN | Enfusion | FY | 2021 | — | — | — | $109.80M | $110.30M | $106.56M | Get Alert |
There have been no specific sales or earnings guidance reported for Enfusion in recent months.
Browse guidance and forecast on all stocks.